Parkside Financial Bank & Trust’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Parkside Financial Bank & Trust’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-138	Closed	-$5K	–	1707
2020 Q2	$5K	Hold	138	–	–	﹤0.01%	957
2020 Q1	$4K	Hold	138	–	–	﹤0.01%	961
2019 Q4	$3K	Hold	138	–	–	﹤0.01%	1115
2019 Q3	$2K	Hold	138	–	–	﹤0.01%	1256
2019 Q2	$2K	Hold	138	–	–	﹤0.01%	1270
2019 Q1	$2K	Buy	+138	New	+$1.76K	﹤0.01%	1245
2018 Q4	–	Sell	-66	Closed	-$2K	–	1636
2018 Q3	$2K	Hold	66	–	–	﹤0.01%	1163
2018 Q2	$1K	Hold	66	–	–	﹤0.01%	1469
2018 Q1	$1K	Buy	66 +29	+78%	+$483	﹤0.01%	1381
2017 Q4	$1K	Hold	37	–	–	﹤0.01%	1297
2017 Q3	$1K	Hold	37	–	–	﹤0.01%	1304
2017 Q2	$1K	Buy	37 +3	+9%	+$46	﹤0.01%	1334
2017 Q1	$0	Hold	34	–	–	﹤0.01%	1574
2016 Q4	$1K	Buy	+34	New	+$449	﹤0.01%	1290

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Parkside Financial Bank & Trust's MNTA Position: Q3 2020 in Review

Parkside Financial Bank & Trust sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 138 shares — an estimated $5K sold.

Parkside Financial Bank & Trust first reported a position in MNTA in Q4 2016 and held it in 14 quarters. The position peaked at $5K in Q2 2020. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

Parkside Financial Bank & Trust reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Parkside Financial Bank & Trust sold 138 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $5K.
Parkside Financial Bank & Trust first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2016 and held it in 14 quarters.
Parkside Financial Bank & Trust's Momenta Pharmaceuticals, Inc. position peaked at $5K in Q2 2020.
211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Parkside Financial Bank & Trust's 13F filing for Q3 2020, filed 6 Nov 2020.